Coca-Cola (KO) Tops Q4 EPS by 3c; offers outlook
Get Alerts KO Hot Sheet
Revenue Growth %: +5.4%
Financial Fact:
DILUTED NET INCOME PER SHARE (in dollars per share): 0.24
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Coca-Cola (NYSE: KO) reported Q4 EPS of $0.55, $0.03 better than the analyst estimate of $0.52. Revenue for the quarter came in at $11.5 billion versus the consensus estimate of $10.7 billion.
OUTLOOK
Full Year 2025
The company expects to deliver organic revenue (non-GAAP) growth of 5% to 6%.
For comparable net revenues (non-GAAP), the company expects a 3% to 4% currency headwind based on the current rates and including the impact of hedged positions, in addition to a slight headwind from acquisitions, divestitures and structural changes.
The company’s underlying effective tax rate (non-GAAP) is estimated to be 20.8% versus 18.6% in 2024. This includes the impact of several countries enacting the global minimum tax regulations and does not include the impact of ongoing tax litigation with the IRS, if the company were not to prevail.
The company expects to deliver comparable currency neutral EPS (non-GAAP) growth of 8% to 10%.
The company expects comparable EPS (non-GAAP) growth of 2% to 3%, versus $2.88 in 2024.
Comparable EPS (non-GAAP) percentage growth is expected to include a 6% to 7% currency headwind based on the current rates and including the impact of hedged positions, in addition to a slight headwind from acquisitions, divestitures and structural changes.
The company expects to generate free cash flow excluding the fairlife contingent consideration payment (non-GAAP) of approximately $9.5 billion. This consists of cash flow from operations excluding the fairlife contingent consideration payment (non-GAAP) of approximately $11.7 billion, less capital expenditures of approximately $2.2 billion.
For earnings history and earnings-related data on Coca-Cola (KO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share